Pulmonx Corp

NASDAQ:LUNG USA Medical Devices
Market Cap
$61.05 Million
Market Cap Rank
#20497 Global
#7421 in USA
Share Price
$1.48
Change (1 day)
-8.64%
52-Week Range
$1.31 - $7.77
All Time High
$69.02
About

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ven… Read more

Pulmonx Corp (LUNG) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.136x

Based on the latest financial reports, Pulmonx Corp (LUNG) has a cash flow conversion efficiency ratio of -0.136x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.16 Million) by net assets ($60.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pulmonx Corp - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Pulmonx Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Pulmonx Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pulmonx Corp ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Pulmonx Corp (2013–2024)

The table below shows the annual cash flow conversion efficiency of Pulmonx Corp from 2013 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $85.81 Million $-31.54 Million -0.368x -15.62%
2023-12-31 $118.31 Million $-37.61 Million -0.318x -8.46%
2022-12-31 $154.01 Million $-45.14 Million -0.293x -36.70%
2021-12-31 $193.24 Million $-41.43 Million -0.214x -58.27%
2020-12-31 $226.13 Million $-30.63 Million -0.135x -222.24%
2019-12-31 $-187.38 Million $-20.77 Million 0.111x +0.81%
2018-12-31 $-167.33 Million $-18.39 Million 0.110x -99.85%
2017-12-31 $-63.18K $-4.64 Million 73.407x +10136.98%
2016-12-31 $-2.84 Million $-2.03 Million 0.717x -25.61%
2015-12-31 $-2.65 Million $-2.56 Million 0.964x +1.67%
2014-12-31 $-1.41 Million $-1.34 Million 0.948x +107.46%
2013-12-31 $-1.78 Million $-811.78K 0.457x --